We have developed a polymerase chain reaction assay for the clinical diagnosis of potentially toxinogenic strains of Corynebacterium diphtheriae, the causative agent of diphtheria. A 910-bp amplification product, overlapping a DNA portion encoding both fragments of the diphtheria toxin, has been found in 28 among the 36 strains tested. In addition, effective toxin production, as evidenced by the ability of bacterial culture supernatants to ADP ribosylate eukaryotic elongation factor 2, was determined. In every case, the presence of an amplification product correlated with an ADP-ribosylation activity, thus confirming the diagnosis. The polymerase chain reaction assay herein described is very rapid (2 h) compared with the Elek immunodiffusion test or the guinea pig lethality test. It can provide a convenient and reliable method for laboratories involved in the identification of toxinogenic corynebacteria.
Pathogenic Corynebacterium diphtheriae strains secrete a potent protein toxin called diphtheria toxin (DT) . The ability to produce DT has been observed only in C. diphtheriae and closely related species (1, 6) .
DT, a 58-kDa polypeptide, kills eukaryotic cells by introducing into their cytosol its 21-kDa N-terminal fragment (fragment A). Fragment A is an enzyme which blocks protein synthesis by ADP-ribosylation of the eukaryotic elongation factor 2 (2, 5). Although vaccination has almost completely eradicated diphtheria from developed countries, C. diphtheriae is still sometimes found in clinical isolates.
Classical tests commonly used to demonstrate the pathogenicity of a C. diphtheriae strain are based on the detection of DT, either by a lethal effect upon injection of a culture filtrate into guinea pigs (12) or by direct immunoprecipitation on agar plates (the Elek test) (3) . Both tests give a belated answer to the diagnosis (usually more than 48 h) and are time-consuming to set up.
A rapid screening of toxinogenic C. diphtheriae based on the polymerase chain reaction (PCR) has recently been described (10) . However, we failed to obtain an amplification product with the reported primers.
In this report, we describe a PCR assay involving two other primers, which allows for a rapid and easy identification of bacteria harboring the DT gene. We also clearly establish a relationship between the presence of the DT gene and an ADP-ribosylation of eukaryotic elongation factor 2 activity in culture medium. Our method should provide a fast and accurate test to differentiate toxinogenic from nontoxinogenic C. diphtheriae.
MATERUILS AND METHODS
Bacterial strains and growth conditions. A total of 36 Corynebacterium strains subdivided into three species have been studied: C. diphtheriae ( Figure 1 shows the electropherogram obtained for 8 Corynebacterium strains out of the 36 tested plus 1 C diphtheriae strain from a clinical isolate, not tested for its ADP-ribosylating activity. The primers selected for the detection of the DT gene led to the amplification of the expected 910-bp fragment. In bacterial strains in which the 910-bp amplimer was absent, no amplification product was found (Fig. 1) . To confirm the specificity of the PCR test, the amplified product from strain A102 (10 pl) was hydrolyzed by MboI for 15 min directly in the PCR buffer and produced the two predicted restriction fragments of 710 and 200 bp (Fig. 2) .
Four strains, instead of producing a 910-bp band, gave a very weak signal around 780 bp (data not shown). In culture supernatant were then allowed to grow for four additional days. Under these conditions, they all showed significant ADP-ribosylating activities. In contrast, a 6-day culture of strain no. 35 was still negative (less than 5% activity). When first tested, three strains, known to be toxinogenic by the guinea pig lethality test or by the Elek test, did not reveal significant ADP-ribosylation activity. As a matter of fact, strains no. 3, 12, and 13, first deposited at the Collection de l'Institut Pasteur in 1952 as toxinogenic strains, gave no band either by the PCR method or by ADP-ribosylated elongation factor 2 (Fig. 1, lanes 7 and 8) . The ( Table 1) . Consequently, among the 36 strains studied, all (n = 11) that had previously been found lethal for the guinea pig were also positive by the PCR and ADP-ribosylation assays.
DISCUSSION The results presented in Table 1 show that 27 strains were found positive by the PCR assay. Culture supernatants of these strains exhibited significant ADP-ribosylating activities. Some of these strains (n = 11) were also positive by the guinea pig lethality test. There is thus a relatively good agreement among the results of the PCR assay, the ADPribosylation test, and the guinea pig lethality test.
The PCR test for the detection of toxinogenic Corynebacterium strains proposed in the present study was on strains already identified by biochemical and morphological means as C. diphtheniae, but also as C. pseudotuberculosis or C. diphthenae subsp. ulcerans, sometimes toxinogenic as well (8) . As a consequence, our test is intended for pure bacterial cultures. Moreover, it is known that a given C. diphtheniae strain may be a mixture of both toxinogenic and nontoxinogenic bacteria (13) . This potential bias is overcome either by using mass cultures or by harvesting several colonies with a loopful as a source of DNA for the PCR assay. This might be of importance in routine applications.
Our ADP-ribosylation assay only detects the activity of fragment A in vitro, whereas the animal toxicity supposes a complete and unaltered DT (fragment A and fragment B). This is one of the reasons why we have chosen to amplify a DNA fragment overlapping part of the sequence for both fragments A and B of the DT. Although we have found that PCR and ADP-ribosylating activity are correlated, it must not be concluded that PCR-positive strains are toxinogenic, since no test has been performed with regard to an in vivo toxicity, but they remain potentially toxinogenic (7) . In any case, it is highly recommended in each PCR test to include positive and negative controls. A known toxinogenic Corynebactenum isolate (positive control, e.g., Park-Williams no. 8) would serve both as a size marker and as a yield marker. In our work, the yields of amplified DNA were equivalent in all the PCR-positive strains tested, confirming the reliability of the PCR assay. Moreover, there is no known genetic variation of the DT gene (9) .
The PCR is essentially a specific method. In the absence of repeated DNA sequences or particular sequence features, there is no reason for the appearance of nonspecific bands of any size. The nonspecific very weak amplification product of 780 bp that was obtained for four C. diphtheniae strains and that has been cloned and sequenced does not depart from this rule since it clearly results from a mismatch of DT1 on the total bacterial DNA (it is assumed that no contamination by exogenous DNA occurred). It is not known where and with which matching percentage a DNA sequence close to DT1 is present in the total DNA of the strains considered.
The PCR test described in this report is now routinely used at the Laboratoire des Identifications Bacteriennes. It must be kept in mind that a nontoxinogenic strain potentially remains sensitive to toxinogenic phage infection (4) . An epidemiological survey to identify C. diphtheriae in isolates and a systematic search of toxinogenic strains among these isolates remain to be carried out.
